Wikipedia

Insulin-like growth factor II IRES

Insulin-like growth factor II IRES
RF00483.jpg
Predicted secondary structure and sequence conservation of IRES_IGF2
Identifiers
SymbolIRES_IGF2
RfamRF00483
Other data
RNA typeCis-reg; IRES
Domain(s)Eukaryota
GOGO:0043022
SOSO:0000243
PDB structuresPDBe

The insulin-like growth factor II (IGF-II) internal ribosome entry site IRES is found in the 5' UTR of IGF-II leader 2 mRNA. This RNA element allows cap-independent translation of the mRNA and it is thought that this family may facilitate a continuous IGF-II production in rapidly dividing cells during development.[1] Ribosomal scanning on human insulin-like growth factor II (IGF-II) is hard to comprehend due to one open reading frame and the ability for the hormone to fold into a stable structure.[2]

References

  1. ^ Pedersen SK, Christiansen J, Hansen T, Larsen MR, Nielsen FC (April 2002). "Human insulin-like growth factor II leader 2 mediates internal initiation of translation". The Biochemical Journal. 363 (Pt 1): 37–44. doi:10.1042/0264-6021:3630037. PMC 1222448. PMID 11903044.
  2. ^ van der Velden AW, van Nierop K, Voorma HO, Thomas AA (March 2002). "Ribosomal scanning on the highly structured insulin-like growth factor II-leader 1". The International Journal of Biochemistry & Cell Biology. 34 (3): 286–297. doi:10.1016/S1357-2725(01)00116-9. PMID 11849996.

External links

This article is copied from an article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of GNU Free Documentation License.

Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.